☆ 4.7 Letter

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

DIABETES CARE (2021)

Journal

DIABETES CARE

Volume 44, Issue 8, Pages E160-E162

Publisher

AMER DIABETES ASSOC

DOI: 10.2337/dc21-0074

Keywords

Funding

JDRF
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH) [P30DK116074]
NIH
National Science Foundation
Leona M. and Harry B. Helmsley Charitable Trust
Leona M. and Harry B. Helmsley Charitable Trust funds

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

Journal

DIABETES CARE

Publisher

AMER DIABETES ASSOC

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

Journal

DIABETES CARE

Publisher

AMER DIABETES ASSOC

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper